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The protein kinase C inhibitor H-7 (2-20/aM) inhibited dose-dependently he infectivity of the vesicular stomatitis virus on cultured human 
fibroblasts. Electron microscopy showed that H-7 inhibited the viral entry. H-7 also inhibited the infectivity of four other enveloped viruses, herpes 
simplex I, turkey herpes, vaecinia nd $indbis. Similar results were obtained using staurosporine (2.5 riM), tamoxifen (40/aM). phloretin (140/aM). 
or W-7 (40/aM). However, the infectivity of non-enveloped viruses (e.g. poliomyelitis I) was not inhibited by H-7. These results how that protein 
kinase C is critically involved in the infectivity of enveloped viruses, most probably at the level of viral entry (receptor-mediated endocytosis). 
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1, INTRODUCTION 
The specific entry of viruses into theh ~.arget cells is 
the key process triggering infection and replication. For 
enveloped viruses, this process is accomplished by re- 
ceptor-mediated endocytosis and fusion mechanisms 
[1,2]. The lack of knowledge regarding the (early) mo- 
lecular events of virus/cell-receptor t anslocation across 
the host-cell membrane ultimately impairs the design of 
efficient antiviral therapy. 
The well-known protein kinase C (PKC) [3,4] was 
recently found to promote the internalization of several 
cell-surface receptors (i.e. T-cell surface CD3 complex, 
epidermal growth factor receptor) (for review see [5]). 
We have previously shown that PKC is implicated in the 
Fee'-receptor mediated endocytosis of human neutro- 
phils [6], and in the internalization of cell-membrane 
phospholipase C [7]. Therefore we tested the effect of 
selective PKC inhibitors on viral entry and infectivity. 
2. MATERIALS AND METHODS 
2.1. CeUs 
Confluent monolayers of human embryo fibroblasts (HEF)or  
chicken embryo fibroblasts (CEF) were grown in Eagle's medium 
supplemented with 10% fetal calf serum. 2 mM glutamine, 100 U/ml 
penicillin and were used 3-4 days after seeding [8,9]. 
2.2. Viruses 
Vesicular stomatitis virus (VSV) (Indiana strain), herpes simplex I
virus (HSV-I) (Maclntyre strain), poliomyelitis virus I (Mahoney 
strain), vaccinia virus (Elstree strain) and Sindbis virus (Ar-339 strain) 
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were passaged and assayed on HEF cells, and turkey herpes virus 
(THV) (Calnek strain) on CEF cells. 
2.3. Protein kimtse C inhibitors 
H-7 (l-(5-isoquinoylsulfonyl)-2-methylpiperazine) [10] was kindly 
provided by Prof. H. Hidaka, Nagoya University, Japan. Staurospo- 
rine [I I], tamoxifcn [12], phloretin [13] and W-7 (N-(6-aminohexyl)-5- 
chloro-l-naphtalene-sulfonamide) [14] were purchased from Sigma 
(St. Louis, MO). 
2.4. Antibodies directed to cell-membrane phospholipases 
Inhibitory antibodies directed to cell-membrane phospholipases C 
(phosphoinositide-preferring, PLC-PI, or phosphatidylcholine-prefer- 
ring. PLC-PC) and to phospholipase A, (PLA2) were obtained as 
described [15-17]. 
2.5. Viral infectivity re:rays 
Cells were treated for 1 h with PKC inhibitors or antiphospholipase 
antibodies, then washed twice in Eagle's medium, and challenged with 
viruses (0.01 TCIDs0/cell) (TCID, tissue culture infectious dose). Virus 
samples taken at the indicated postinfection intervals were tenfold 
diluted and titrated on HEF cells or CEF cells grown on microtest 
tissue culture flasks (Falcon Plastics, Los Angeles, CA) as previously 
described [8]. Four assays (10 ~ cells/assay) were carried out for each 
sample and each experiment was repeated at least twice. Toxicity 
assays for all chemicals or antibodies were done using the Trypan blue 
exclusion test. 
2.6. Electron microscopy 
HEF cells were processed in the plastic dishes in which they were 
grown (5 x l0 s cells/sample). After treatment for I h with 20/aM H-7 
or culture medium at 37°C (for control), cells were twice washed 
in Eagle's medium, and challenged with VSV (1 TCID~dcelI) for 1 h, 
at 37°C. HEF monolayers were then washed, equilibrated at room 
temperature (22+2°C), washed for 30 s in 0.075 M cacodilate 
buffer containing 3% sucrose, prefixed 5 rain in 2.5% buffered 
glutaraldehyde, briefly washed and posttixed in 2% OsO4 solution 
for 10 rain, at 4°C. Specimens were dehydrated in a graded series 
of ethanols and embedded in Epon. Ultra-thin sections were 
cut with an American Optical ultramicrotome, stained with uranyl 
acetate and lead citrate, and examined under a Philips 301 electron 
microscope. 
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Fig, 1. The dose-dependent inhibitory effect of H-7 (! h pretreqtment 
of fibroblasts) on the infectivity of VSV (empty circle) or HSV-I (solid 
circle). Viral titers (-IogTCIDsdml) are shown for the 24 h postinfec- 
tion interval. Each point is the mean of four determinations _+SE. 
Fig, 2. Electron microscope image of  a human fibroblast in culture 
pretreated I h with H-7 (20llM) and then challenged with VSV. Note 
two VSV virions attached to the cell-membrane (arrows). No VSV 
virions penetrated into the cell. cp, cytoplasmic protrusion" rer. rough 
endoplasmic r ticulum: X, microtubules (cross section): es, extracellu- 
lar space. 
ruses, we used antibodies directed to cell-membrane 
phospholipases, shown to inhibit DAG production in 
living cells, including fibroblasts [ 15- ! 7]. But the inhibi- 
tory antibodies against cell-membrane PLC-PI, PLC- 
PC, PLA, (10-I00/ag/ml) or rabbit non-immune IgG 
(640/tg/ml) (for control) did not mimick the effect of 
PKC inhibitors on VSV infectivity in HEF cells or on 
THV in CEF cells. 
The infectivity of a non-enveloped virus, (poliomyeli- 
tis I) was not modified by 1 h pretreatment of FIEF cells 
with 20/aM H-7. 
3. RESULTS 
Fig. 1 shows that 1 h pretreatment with H-7 (2-20 
/aM) inhibited in a dose-dependent manner the infectiv- 
ity of VSV and of HSV-l on cultured fibroblasts. The 
KI value of H-7 against PKC is 6.0/~M [10]. Addition 
of H-7 l h prior to the viral challenge xerted the maxi- 
mal antiviral effects. The addition of H-7 3-24 h before 
the viral challenge resulted in significantly lower anti- 
viral activities, while maintaining the inhibitor in cul- 
ture medium after virus challenge nhanced the anti- 
viral effect (not shown). 
Electron microscopy showed that I h pretreatment of
HEF cells with 20/aM H-7 impaired the VSV entry 
(Table I). The number of internalized VSV particles was 
significantly decreased (P<0.05). Fig. 2 shows a typical 
electron microscope image of VSV particles bound to 
the cell surface. 
Several PKC inhibitors, staurosporine (2.5 nM), ta- 
moxifen (40/aM), phloretin (140/aM) and (W-7) (40 
/aM) inhibited in a similar manner (1-1.5 log viral titer) 
the infectivity of the other enveloped viruses (vaccinia, 
Sindbis or THV). 
To investigate the possible mechanism by which PKC 
inhibitors inhibited the infectivity of the enveloped vi- 
4. DISCUSSION 
Our results show that I h pretreatment of fibroblasts 
with five different drugs, which share the quality of 
being PKC inhibitors, inhibited the infectivity of several 
enveloped viruses belonging to different families: rhab- 
doviridae (VSV), herpesviridae (HSV-I and THV), pox- 
viridae (vaccinia) and togaviridae (Sindbis). Electron 
microscopy showed that, in fact, the H-7 pretreatment 
of fibroblasts inhibited the entry process. Similar results 
Table I 
Inhibitor)' effect of H-7 (20/~M) on VSV entry into human fibroblasts 
in culture 
Virus particles* 
Bound to the cell surface Inside the cell 
VSV** 2.3 _ + 0.4 6.1 = -~ 1.2 
H-7 + VSV*** 5,4 + 1.3 I.l - 0.3 
*The results are given per 3 ce!7 profiles (tile whole contour of tile cell 
visible on a given section) 
**30 cell profiles counted 
***33 cell profiles counted 
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were reported by Fields et al. [18] on the entry of an- 
other enveloped virus, the human immunodeficiency 1 
virus, into CD4 positive cells. 
The effect of PKC inhibitors was not mimicked by 
inhibitory antibodies directed to cell-membrane phos- 
pholipases (PLC-PI, PLC-PC or PLA_,), although these 
antibodies decreased basal and agonist-induced produc- 
tion of DAG in living cells [15-17]. Noteworthy, PKC 
inhibitors also inhibited the Fcy-receptor mediated en- 
docytosis in neutrophils, but in that case the antibodies 
were also inhibitory [6], suggesting that the routes for 
PKC activation are different for these two processes. 
Anyway, the cellular receptor for VSV was shown to 
contain phosphatidylserine [19], which is a cofactor of 
PKC [3,4], while vaccinia virus was found to bind the 
epidermal growth factor receptor [20], which is interna- 
lized by PKC [5]. 
Since the calmodulin antagonist W-7, which inhibits 
PKC indirectly via phospholipid interactions [14], mi- 
micked the antiviral effects of PKC inhibitors, it is 
tempting to speculate that, in addition to PKC, some 
homologous proteins might also be involved in the entry 
process of enveloped viruses. Indeed, it was recently 
shown that synaptic vesicle exocytosis for neurotrans- 
mitter release is mediated by a vesicle protein homolo- 
gous to the regulatory domain of PKC [21]. Interesting- 
ly, the lack of inhibitory effect of H-7 on the infectivity 
of non-enveloped viruses (e.g. poliomyelitis I) suggests 
major differences between the entry pathways of enve- 
loped versus non-enveloped viruses. 
Finally, our results showed that PKC inhibitors inhi- 
bited the infectivity of different enveloped viruses, most 
probably at the level of viral entry, although viral at- 
tachment to the cell membrane was not impaired. 
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